skip to main content
UK Health Security Agency

Sp2/0.Ag14-TurboDoma

Sp2/0.Ag14-TurboDoma

Catalogue No.

03092501

Cell Line Name

Sp2/0.Ag14-TurboDoma

Cell Line Description

Sp2/0-Ag14 cell line (ECACC catalogue no. 85072401) adapted to grow in the chemically defined protein- and peptide-free medium TurboDoma (Cell Culture Technologies). Suitable for use as a fusion parent for serum-free generation of hybridomas as well as a host for the production of recombinant proteins.

Characteristics

Tissue of Origin

Not specified

Karyotype

Not specified

Applications

Fusion partner for generation of serum-free hybridomas, host for the expression of recombinant genes

Disease

None Stated

Culture Conditions

Cell Type

Lymphoblastoid

Subculture Routine

Viability may be poor on resuscitation and may initially decrease further. Full recovery may take up to 2 weeks. A centrifugation step to remove the cryoprotectant is essential. Rapidly thaw the frozen ampoule in a water bath at 37°C for 1-2 minutes. Transfer the contents to a centrifuge tube and slowly add 5-10ml of pre-warmed growth media. Remove a sample for counting. Centrifuge at 100g for 2-3 minutes to pellet cells and seed at a relatively high density of 5-7 x 10⁵ cells/ml. Leave culture flask upright and observe regularly until viable proliferating cells are seen. Once established use a split ratio of 1:2 approximately every 4 to 5 days; 5% CO₂; 37°C.

Culture Medium

TurboDoma medium (Cell Culture Technologies http://www.cellculture.com/) + 4mM Glutamine. When freezing cells down use TurboDoma medium (50:50 conditioned medium:fresh medium) + 4mM Glutamine + 10% DMSO.

Growth Mode

Suspension

Additional Info

Depositor

Joint deposit from: Dr. Ferruccio Messi of Cell Culture Technologies Inc., Via al Chioso 14, 6929 Gravesano, Switzerland, Rene Fischer of the Laboratory for Organic Chemistry, ETH Zurich, 8093 Zurich, Switzerland, and Ing. Claudio Strebel of CePower Inc., Einsiedlerstr. 29, 8820 Waedenswil, Switzerland. Supported by the Swiss Foundation FFVFF

Country of Origin

Switzerland

Hazard Group (ACDP)

Hazard Group (ACDP) 2

Applications

References

Shulman M, Wilde CD, Köhler G 1978 A better cell line for making hybridomas secreting specific antibodies. Nature. 276(5685):269-70 PMID: 714156. Ozato K, Sachs DH 1981 Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression. J Immunol. 126(1):317-21 PMID: 6935293.

Available Formats

  • Frozen

If use of this culture results in a scientific publication, it should be cited in the publication as: Sp2/0.Ag14-TurboDoma (ECACC 03092501).

Unless specified otherwise, at ECACC we routinely handle all of our cell lines at containment level 2 in accordance with the ACDP guidelines (Advisory Committee on Dangerous Pathogens) (UK). All cell cultures have the potential to carry as yet unidentified adventitious agents. It is the responsibility of the end user to ensure that their facilities comply with biosafety regulations for their own country. ACDP Guidance: Biological agents: Managing the risks in laboratories and healthcare premises.

The Culture Collections represent deposits of cultures from world-wide sources. While every effort is made to ensure details distributed by Culture Collections are accurate, Culture Collections cannot be held responsible for any inaccuracies in the data supplied. References where quoted are mainly attributed to the establishment of the cell culture and not for any specific property of the cell line, therefore further references should be obtained regarding cell culture characteristics. Passage numbers where given act only as a guide and Culture Collections does not guarantee the passage number stated will be the passage number received by the customer.

Cultures supplied by Culture Collections are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.